TC
IHI icon

Trilogy Capital’s iShares US Medical Devices ETF IHI Stock Holding History

Trilogy Capital’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-18
Closed -$1K – 334
2018
Q3 		$1K Buy
+18
New +$640 ﹤0.01% 565

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $49B AUM 17.78% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Trilogy Capital's IHI Position: Q4 2018 in Review

Trilogy Capital sold out of iShares US Medical Devices ETF (IHI) in Q4 2018, closing a stake of 18 shares — an estimated $1K sold.

Trilogy Capital first reported a position in IHI in Q3 2018 and held it in 1 quarter. The position peaked at $1K in Q3 2018. 233 funds tracked by Wall St. Rank hold IHI as of Q4 2018.

  • Trilogy Capital reported no remaining iShares US Medical Devices ETF position as of Q4 2018 after selling out during the quarter.
  • Trilogy Capital sold 18 iShares US Medical Devices ETF shares in Q4 2018, an estimated $1K.
  • Trilogy Capital first reported a position in iShares US Medical Devices ETF in Q3 2018 and held it in 1 quarter.
  • Trilogy Capital's iShares US Medical Devices ETF position peaked at $1K in Q3 2018.
  • 233 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q4 2018.

Based on Trilogy Capital's 13F filing for Q4 2018, filed 15 Jan 2019.